Ana Margarida Monteiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ana Margarida Monteiro has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Olinda Marques
Department of Endocrinology, Hospital de Braga, Braga, Portugal
13 shared publicationsMarta Alves
9 shared publicationsVera Fernandes
Serviço de Endocrinologia. Hospital de Braga. Braga
7 shared publicationsFernando Manso
Serviço de Cirurgia Geral, Hospital de Braga, Braga, Portugal
3 shared publicationsCarolina Neves
2 shared publicationsClaudia Matta-Coelho
2 shared publications
Latest Publications
- 22 July 2022
- Published by Springer Nature in Pituitary
- Vol. 25 (6) , 780-794
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis
Purpose Vertebral fractures (VFs) are a potential complication in acromegaly. However, the etiology of this skeletal fragility is unknown. This review aimed to evaluate the effect of acromegaly on VFs, bone turnover, areal bone mineral density (aBMD), and bone quality/microarchitecture. The effect of disease activity and gonadal status in these determinants of skeletal fragility was also evaluated. Methods Articles published in English until September 6, 2020 on PubMed and Embase that reported at least one determinant of skeletal fragility in acromegalic patients, were included. Odds ratio (OR) to evaluate the risk of VFs and the standardized mean difference (SMD) to evaluate bone turnover, aBMD and bone quality/microarchitecture were calculated. Results Fifty-eight studies met eligibility criteria, assembling a total of 2412 acromegalic patients. Of these, 49 studies were included in the meta-analysis. Acromegalic patients, when compared to non-acromegalic patients, had higher risk of VFs [OR 7.00; 95% confidence interval (CI) 2.80–17.52; p < 0.0001], higher bone formation (SMD 1.14; 95% CI 0.69–1.59; p < 0.00001), higher bone resorption (SMD 0.60; 95% CI 0.09–1.10; p = 0.02) and higher aBMD at the femoral neck (SMD 0.36; 95% CI 0.15–0.57; p = 0.0009). No significant differences were found regarding aBMD at lumbar spine. Considering the results of the different techniques evaluating bone quality/microarchitecture, the main reported alterations were a decrease in trabecular bone thickness and density, and an increase in trabecular separation. The presence of active disease and/or hypogonadism were associated with worst results. Conclusion Patients with acromegaly are at increased risk of VFs, mainly because of deterioration in bone microarchitecture.
- 22 July 2022
- Published by Springer Nature in Pituitary
- Vol. 25 (6) , 780-794
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis
Purpose Vertebral fractures (VFs) are a potential complication in acromegaly. However, the etiology of this skeletal fragility is unknown. This review aimed to evaluate the effect of acromegaly on VFs, bone turnover, areal bone mineral density (aBMD), and bone quality/microarchitecture. The effect of disease activity and gonadal status in these determinants of skeletal fragility was also evaluated. Methods Articles published in English until September 6, 2020 on PubMed and Embase that reported at least one determinant of skeletal fragility in acromegalic patients, were included. Odds ratio (OR) to evaluate the risk of VFs and the standardized mean difference (SMD) to evaluate bone turnover, aBMD and bone quality/microarchitecture were calculated. Results Fifty-eight studies met eligibility criteria, assembling a total of 2412 acromegalic patients. Of these, 49 studies were included in the meta-analysis. Acromegalic patients, when compared to non-acromegalic patients, had higher risk of VFs [OR 7.00; 95% confidence interval (CI) 2.80–17.52; p < 0.0001], higher bone formation (SMD 1.14; 95% CI 0.69–1.59; p < 0.00001), higher bone resorption (SMD 0.60; 95% CI 0.09–1.10; p = 0.02) and higher aBMD at the femoral neck (SMD 0.36; 95% CI 0.15–0.57; p = 0.0009). No significant differences were found regarding aBMD at lumbar spine. Considering the results of the different techniques evaluating bone quality/microarchitecture, the main reported alterations were a decrease in trabecular bone thickness and density, and an increase in trabecular separation. The presence of active disease and/or hypogonadism were associated with worst results. Conclusion Patients with acromegaly are at increased risk of VFs, mainly because of deterioration in bone microarchitecture.
- Open Access
- 27 June 2022
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 66 (4) , 481-488
The role of neck ultrasound in the follow-up of low- and intermediate- risk papillary thyroid cancer
Objective: The optimal time for a neck ultrasound (US) in the follow-up of papillary thyroid cancer (PTC) after the first year is undetermined. We aimed to verify the utility of routine neck US in the surveillance of patients diagnosed with low- and intermediate-risk PTC with no evidence of disease at the one-year assessment. Materials and methods: We conducted a retrospective longitudinal study of patients with low- and intermediate-risk PTC with normal neck US, unstimulated serum thyroglobulin (Tg) < 1
- 27 June 2022
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 66 (4) , 481-488
Open AccessThe role of neck ultrasound in the follow-up of low- and intermediate- risk papillary thyroid cancer
Objective: The optimal time for a neck ultrasound (US) in the follow-up of papillary thyroid cancer (PTC) after the first year is undetermined. We aimed to verify the utility of routine neck US in the surveillance of patients diagnosed with low- and intermediate-risk PTC with no evidence of disease at the one-year assessment. Materials and methods: We conducted a retrospective longitudinal study of patients with low- and intermediate-risk PTC with normal neck US, unstimulated serum thyroglobulin (Tg) < 1
- 14 March 2022
- Published by Springer Nature in Hormones
- Vol. 21 (2) , 287-293
Postpartum reclassification test in gestational diabetes: can the test be reduced to 1 hour?
Purpose In gestational diabetes mellitus (GDM), a postpartum oral glucose tolerance test (OGTT) is recommended. However, poor adherence to this procedure has been described, and the time required is one of the reasons. Our aims were to identify predictive factors for abnormal 2-h reclassification OGTT values, including OGTT 1-h glucose, and, if it was a factor, to determine the 1-h cutoff point that best identifies abnormal values at 2 h. Methods This was a retrospective study of 769 patients diagnosed with GDM between 2014 and 2019 in a tertiary center. The sample was divided into two groups according to the presence/absence of abnormal 2-h reclassification values, and predictive factors were studied. To determine the 1-h glycemia cutoff point capable of identifying 2-h changes, a ROC curve was drawn and the Youden index was used. Results The mean age of included women was 33.6 ± 4.95 years: 70 of them (9.1%) had an abnormal 2-h test result. Women with a history of GDM (OR = 3.41, p = .012) and higher 1-h glycemia value (OR = 1.05, p < .001) had a higher risk of developing an abnormal 2-h test result. One-hour glycemia ≥ 142 mg/dL had a sensitivity of 91.4% and specificity of 75.1% to identify changes in the test at 2 h; area under the curve to predict 2-h changes was 0.90 (CI 95%: 0.86 – 0.93). Conclusion Glucose measurement at 1 h predicts alterations at 2 h in the reclassification test with excellent diagnostic accuracy, and the cutoff point of ≥ 142 mg/dL presents high sensitivity. These findings could serve as a foundation for a possible future redefinition of the OGTT procedure, but further investigation is required.
- 14 March 2022
- Published by Springer Nature in Hormones
- Vol. 21 (2) , 287-293
Postpartum reclassification test in gestational diabetes: can the test be reduced to 1 hour?
Purpose In gestational diabetes mellitus (GDM), a postpartum oral glucose tolerance test (OGTT) is recommended. However, poor adherence to this procedure has been described, and the time required is one of the reasons. Our aims were to identify predictive factors for abnormal 2-h reclassification OGTT values, including OGTT 1-h glucose, and, if it was a factor, to determine the 1-h cutoff point that best identifies abnormal values at 2 h. Methods This was a retrospective study of 769 patients diagnosed with GDM between 2014 and 2019 in a tertiary center. The sample was divided into two groups according to the presence/absence of abnormal 2-h reclassification values, and predictive factors were studied. To determine the 1-h glycemia cutoff point capable of identifying 2-h changes, a ROC curve was drawn and the Youden index was used. Results The mean age of included women was 33.6 ± 4.95 years: 70 of them (9.1%) had an abnormal 2-h test result. Women with a history of GDM (OR = 3.41, p = .012) and higher 1-h glycemia value (OR = 1.05, p < .001) had a higher risk of developing an abnormal 2-h test result. One-hour glycemia ≥ 142 mg/dL had a sensitivity of 91.4% and specificity of 75.1% to identify changes in the test at 2 h; area under the curve to predict 2-h changes was 0.90 (CI 95%: 0.86 – 0.93). Conclusion Glucose measurement at 1 h predicts alterations at 2 h in the reclassification test with excellent diagnostic accuracy, and the cutoff point of ≥ 142 mg/dL presents high sensitivity. These findings could serve as a foundation for a possible future redefinition of the OGTT procedure, but further investigation is required.
- 1 February 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (2) , 161
Obesity and COVID-19: A Forgotten Relationship
Obesity and COVID-19: A Forgotten Relationship
- 1 February 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (2) , 161
Obesity and COVID-19: A Forgotten Relationship
Obesity and COVID-19: A Forgotten Relationship
- 9 March 2018
- Published by BMJ in BMJ Case Reports
- Vol. 2018
Iatrogenic water intoxication in a female adolescent with hypopituitarism
The authors report a case of a 15-year-old girl with hypopituitarism due to pituitary stalk interruption syndrome diagnosed in the neonatal period. The patient was admitted to the emergency room with impaired consciousness and hypoglycaemia. The day before, she increased her water intake to about 1.5 L to perform a pelvic ultrasound. In the following hours, she developed vomiting and food refusal. Blood analysis revealed hypoglycaemia, hyponatraemia, decreased serum osmolality and normal urinary density. Hyponatraemia and adrenal crisis were managed with a gradual but slow resolution of consciousness and electrolytic balance. This case describes an episode of iatrogenic water intoxication in a patient under desmopressin treatment. Although uncommon, dilutional hyponatraemia is the main complication of desmopressin treatment. We reinforce the importance of patients and caregivers’ long-life education for the potential complications of an increase in fluid intake in patients treated with desmopressin.
- 9 March 2018
- Published by BMJ in BMJ Case Reports
- Vol. 2018
Iatrogenic water intoxication in a female adolescent with hypopituitarism
The authors report a case of a 15-year-old girl with hypopituitarism due to pituitary stalk interruption syndrome diagnosed in the neonatal period. The patient was admitted to the emergency room with impaired consciousness and hypoglycaemia. The day before, she increased her water intake to about 1.5 L to perform a pelvic ultrasound. In the following hours, she developed vomiting and food refusal. Blood analysis revealed hypoglycaemia, hyponatraemia, decreased serum osmolality and normal urinary density. Hyponatraemia and adrenal crisis were managed with a gradual but slow resolution of consciousness and electrolytic balance. This case describes an episode of iatrogenic water intoxication in a patient under desmopressin treatment. Although uncommon, dilutional hyponatraemia is the main complication of desmopressin treatment. We reinforce the importance of patients and caregivers’ long-life education for the potential complications of an increase in fluid intake in patients treated with desmopressin.
- Open Access
- 29 November 2017
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 30 (11) , 813-817
Metabolic Activity in the Visceral and Subcutaneous Adipose Tissues by FDG-PET/CT in Obese Patients
Introduction: The emerging role of the 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in the study of the metabolic activity and inflammation in adipose tissue indicates that it might be a reliable tool to complement the risk stratification in obesity. The aims of this study were the evaluation of 18F-fluorodeoxyglucose uptake by visceral adipose tissues and subcutaneous adipose tissues and to determine eventual differences in patients with and without obesity.Material and Methods: Retrospective study of adult patients who underwent whole body 18F-fluorodeoxyglucose-positron emission tomography/ computed tomography scanning between July and August of 2016. Statistical analysis: SPSS™ software v.20. Statisticalsignificance: p < 0.05.Results: We assessed fluorodeoxyglucose-positron emission tomography/computed tomography scans from 156 patients (58.3% of males) with a mean age of 61.0 ± 14.1 years. Half of the patients had a body mass index ≥ 25.0 kg/m2 and 15.4% (n = 24) were obese. In both groups, the mean 18F-fluorodeoxyglucose uptake was higher in visceral adipose tissues. There were no differences in 18F-fluorodeoxyglucose uptake in visceral adipose tissues between the groups. Obese patients had lower density of adipose tissue,both in subcutaneous adipose tissues and in visceral adipose tissues. Abdominal circumference and density of visceral adipose tissueshad a positive predictive value in the mean 18F-fluorodeoxyglucose uptake in visceral adipose tissues. Discussion: Through a non-invasive test, this study demonstrated a significant higher metabolic activity in visceral adipose tissues in both obese and non-obese patients. According to our results, abdominal circumference was an important determinant in 18F-fluorodeoxyglucose uptake in visceral adipose tissues. We also demonstrated that obese patients had differences in adipose tissue quality.Conclusion: Our findings reinforce the importance of the adipose tissue quality and distribution for metabolic risk stratification.
- 29 November 2017
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 30 (11) , 813-817
Open AccessMetabolic Activity in the Visceral and Subcutaneous Adipose Tissues by FDG-PET/CT in Obese Patients
Introduction: The emerging role of the 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in the study of the metabolic activity and inflammation in adipose tissue indicates that it might be a reliable tool to complement the risk stratification in obesity. The aims of this study were the evaluation of 18F-fluorodeoxyglucose uptake by visceral adipose tissues and subcutaneous adipose tissues and to determine eventual differences in patients with and without obesity.Material and Methods: Retrospective study of adult patients who underwent whole body 18F-fluorodeoxyglucose-positron emission tomography/ computed tomography scanning between July and August of 2016. Statistical analysis: SPSS™ software v.20. Statisticalsignificance: p < 0.05.Results: We assessed fluorodeoxyglucose-positron emission tomography/computed tomography scans from 156 patients (58.3% of males) with a mean age of 61.0 ± 14.1 years. Half of the patients had a body mass index ≥ 25.0 kg/m2 and 15.4% (n = 24) were obese. In both groups, the mean 18F-fluorodeoxyglucose uptake was higher in visceral adipose tissues. There were no differences in 18F-fluorodeoxyglucose uptake in visceral adipose tissues between the groups. Obese patients had lower density of adipose tissue,both in subcutaneous adipose tissues and in visceral adipose tissues. Abdominal circumference and density of visceral adipose tissueshad a positive predictive value in the mean 18F-fluorodeoxyglucose uptake in visceral adipose tissues. Discussion: Through a non-invasive test, this study demonstrated a significant higher metabolic activity in visceral adipose tissues in both obese and non-obese patients. According to our results, abdominal circumference was an important determinant in 18F-fluorodeoxyglucose uptake in visceral adipose tissues. We also demonstrated that obese patients had differences in adipose tissue quality.Conclusion: Our findings reinforce the importance of the adipose tissue quality and distribution for metabolic risk stratification.
- Open Access
- 22 September 2017
- Published by Academia CUF in Gazeta Médica
Hipertensão de Causa Endócrina: Hiperaldosteronismo Primário por Síndrome de Conn
O hiperaldosteronismo primário é uma das principais causas de hipertensão secundária. Carateriza-se pela produção inapropriada e parcialmente autónoma de aldosterona pela suprarrenal. O diagnóstico pressupõe um rácio aldosterona/renina elevado e, na maioria dos casos, uma prova confirmatória positiva. O tratamento preconizado é a adrenalectomia laparoscópica ou terapêutica médica com antagonistas dos recetores dos mineralocorticoides. Descrevemos o caso de uma doente de 55 anos com hipocaliemia e hipertensão arterial refratária à terapêutica com 16 anos de evolução. A investigação diagnóstica foi compatível com hiperaldosteronismo primário por adenoma adrenal unilateral. Foi submetida a adrenalectomia laparoscópica direita, com melhoria franca do quadro clínico. O caso clínico apresentado pretende evidenciar uma causa de hipertensão secundária cuja identificação e orientação adequada pode permitir a resolução da hipertensão. Recebido: 10/10/2016 - Aceite: 03/06/2017
- 22 September 2017
- Published by Academia CUF in Gazeta Médica
Open AccessHipertensão de Causa Endócrina: Hiperaldosteronismo Primário por Síndrome de Conn
O hiperaldosteronismo primário é uma das principais causas de hipertensão secundária. Carateriza-se pela produção inapropriada e parcialmente autónoma de aldosterona pela suprarrenal. O diagnóstico pressupõe um rácio aldosterona/renina elevado e, na maioria dos casos, uma prova confirmatória positiva. O tratamento preconizado é a adrenalectomia laparoscópica ou terapêutica médica com antagonistas dos recetores dos mineralocorticoides. Descrevemos o caso de uma doente de 55 anos com hipocaliemia e hipertensão arterial refratária à terapêutica com 16 anos de evolução. A investigação diagnóstica foi compatível com hiperaldosteronismo primário por adenoma adrenal unilateral. Foi submetida a adrenalectomia laparoscópica direita, com melhoria franca do quadro clínico. O caso clínico apresentado pretende evidenciar uma causa de hipertensão secundária cuja identificação e orientação adequada pode permitir a resolução da hipertensão. Recebido: 10/10/2016 - Aceite: 03/06/2017
- Open Access
- 1 January 2017
- Published by Touch Medical Media, Ltd. in touchREVIEWS in Endocrinology
- Vol. 13 (02) , 99-101
Type 2 Diabetes Decompensation as the Clinical Presentation of Thyroid Storm – Cause or Consequence?
This case study aims to discuss the unusual forms of hyperthyroidism presentation, the nonspecific symptoms and precipitating events. A 70-year-old male was taken to the emergency department for hyperglycaemia, nausea, vomiting and altered mental status with a week of evolution. He had a past medical history of type 2 diabetes, hypertension and dyslipidemia. He had no history of any recent intercurrent illness or infection. At the emergency room, besides hyperglycaemia, ketonemia and slightly elevated C-reactive protein, the basic laboratory panel workup was normal, as was the head computed tomography. He was admitted for metabolic compensation and to study the altered neurological status. During hospitalisation, despite the good glycemic control, he had no improvements in neurological status. At day four of hospitalisation, thyrotoxicosis with thyroid storm criteria was diagnosed. He started on adequate treatment with complete clinical recovery. The associated morbidity and mortality of thyroid storm requires immediate recognition and treatment. Elderly patients are frequently misdiagnosed or diagnosed later due to fewer and less pronounced signs and symptoms.
- 1 January 2017
- Published by Touch Medical Media, Ltd. in touchREVIEWS in Endocrinology
- Vol. 13 (02) , 99-101
Open AccessType 2 Diabetes Decompensation as the Clinical Presentation of Thyroid Storm – Cause or Consequence?
This case study aims to discuss the unusual forms of hyperthyroidism presentation, the nonspecific symptoms and precipitating events. A 70-year-old male was taken to the emergency department for hyperglycaemia, nausea, vomiting and altered mental status with a week of evolution. He had a past medical history of type 2 diabetes, hypertension and dyslipidemia. He had no history of any recent intercurrent illness or infection. At the emergency room, besides hyperglycaemia, ketonemia and slightly elevated C-reactive protein, the basic laboratory panel workup was normal, as was the head computed tomography. He was admitted for metabolic compensation and to study the altered neurological status. During hospitalisation, despite the good glycemic control, he had no improvements in neurological status. At day four of hospitalisation, thyrotoxicosis with thyroid storm criteria was diagnosed. He started on adequate treatment with complete clinical recovery. The associated morbidity and mortality of thyroid storm requires immediate recognition and treatment. Elderly patients are frequently misdiagnosed or diagnosed later due to fewer and less pronounced signs and symptoms.
- Open Access
- 1 July 2016
- Published by S. Karger AG in Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo
- Vol. 11 (2) , 262-267
Diabetes e cirurgia de ambulatório – protocolo de atuação no período perioperatório
ResumoA diabetes mellitus é uma doença crónica de elevada prevalência em todo o mundo. Dado que os procedimentos cirúrgicos em regime de ambulatório têm aumentado significativamente, surge a necessidade de elaboração de um protocolo para o controlo glicémico destes doentes neste contexto. A avaliação cuidadosa pré‐operatória é fundamental e permite antecipar alterações no controlo glicémico e evitar complicações perioperatórias. Existe evidência crescente de que a otimização do controlo glicémico no período perioperatório se associa a diminuição da morbilidade e mortalidade.Com este artigo pretende‐se divulgar um protocolo atualizado, como proposta de atuação no controlo glicémico de pessoas com diabetes submetidas a procedimentos cirúrgicos em unidades de ambulatório.AbstractDiabetes mellitus is a chronic disease highly prevalent throughout the world. Since outpatient surgical procedures have significantly increased, there is a need to formulate a protocol for glycemic control of these patients in this context. Careful preoperative evaluation is crucial and allows us to anticipate changes in glycemic control and avoid perioperative complications. There is growing evidence that the optimization of glycemic control in the perioperative period is associated with decreased morbidity and mortality.With this article we intend to publish an updated protocol as an acting proposal on glycemic control in diabetic patients undergoing surgical procedures in outpatient units
- 1 July 2016
- Published by S. Karger AG in Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo
- Vol. 11 (2) , 262-267
Open AccessDiabetes e cirurgia de ambulatório – protocolo de atuação no período perioperatório
ResumoA diabetes mellitus é uma doença crónica de elevada prevalência em todo o mundo. Dado que os procedimentos cirúrgicos em regime de ambulatório têm aumentado significativamente, surge a necessidade de elaboração de um protocolo para o controlo glicémico destes doentes neste contexto. A avaliação cuidadosa pré‐operatória é fundamental e permite antecipar alterações no controlo glicémico e evitar complicações perioperatórias. Existe evidência crescente de que a otimização do controlo glicémico no período perioperatório se associa a diminuição da morbilidade e mortalidade.Com este artigo pretende‐se divulgar um protocolo atualizado, como proposta de atuação no controlo glicémico de pessoas com diabetes submetidas a procedimentos cirúrgicos em unidades de ambulatório.AbstractDiabetes mellitus is a chronic disease highly prevalent throughout the world. Since outpatient surgical procedures have significantly increased, there is a need to formulate a protocol for glycemic control of these patients in this context. Careful preoperative evaluation is crucial and allows us to anticipate changes in glycemic control and avoid perioperative complications. There is growing evidence that the optimization of glycemic control in the perioperative period is associated with decreased morbidity and mortality.With this article we intend to publish an updated protocol as an acting proposal on glycemic control in diabetic patients undergoing surgical procedures in outpatient units
- Open Access
- 1 July 2016
- Published by S. Karger AG in Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo
- Vol. 11 (2) , 197-201
Lipid profile and persistent lipid abnormalities in diabetic patients – a retrospective study
IntroductionThe purposes of this study are the characterization the lipid profile and the suitability of the statins treatment according to the cardiovascular profile. Also, in statin-treated patients, we aim to determine the prevalence of persistent lipid abnormalities.Material and methodsObservational and retrospective study of outpatient diabetic patients of a hospital consultation, between Jun/2014 and Jun/2015.ResultsOf the 199 diabetic patients included, 58.6% were treated with statins and only 13.9% were treated with statin dose adequate for its cardiovascular profile. The patients without overt cardiovascular disease had higher total cholesterol (178.0 vs 157.5mg/dl; p=0.003), HDL-C (51.0 vs 43.0mg/dl; p=0.005), LDL-C (97.0 vs 79.0mg/dl; p=0.004) and non-HDL-C (127.0 vs 112.5mg/dl; p=0.04) and higher prevalence of patients who achieved HDL-C goals (64.3 vs 33.3%; p<0.0001). Almost half of statin-treated patients (46.8%) failed to achieve the LDL-C goals, 35.8% and 51.6% failed the triglycerides and HDL-C goals, respectively. Only 11.7% achieved all three goals. In statin-treated patients, we found a statistically significant difference between patients with and without cardiovascular disease on the prevalence of patients reaching the target HDL-C (68.1 vs 35.4%; p=0.001). There were no differences in the prevalence of patients who achieved LDL-C and triglyceride goals.Discussion/conclusionThere is a suboptimal utilization of statins and a substantial percentage of diabetic patients that do not achieve the therapeutic goals. We emphasize the need for an effort to optimize the lipid profile of diabetics in order to contribute to reducing the prevalence of cardiovascular diseases in this population
- 1 July 2016
- Published by S. Karger AG in Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo
- Vol. 11 (2) , 197-201
Open AccessLipid profile and persistent lipid abnormalities in diabetic patients – a retrospective study
IntroductionThe purposes of this study are the characterization the lipid profile and the suitability of the statins treatment according to the cardiovascular profile. Also, in statin-treated patients, we aim to determine the prevalence of persistent lipid abnormalities.Material and methodsObservational and retrospective study of outpatient diabetic patients of a hospital consultation, between Jun/2014 and Jun/2015.ResultsOf the 199 diabetic patients included, 58.6% were treated with statins and only 13.9% were treated with statin dose adequate for its cardiovascular profile. The patients without overt cardiovascular disease had higher total cholesterol (178.0 vs 157.5mg/dl; p=0.003), HDL-C (51.0 vs 43.0mg/dl; p=0.005), LDL-C (97.0 vs 79.0mg/dl; p=0.004) and non-HDL-C (127.0 vs 112.5mg/dl; p=0.04) and higher prevalence of patients who achieved HDL-C goals (64.3 vs 33.3%; p<0.0001). Almost half of statin-treated patients (46.8%) failed to achieve the LDL-C goals, 35.8% and 51.6% failed the triglycerides and HDL-C goals, respectively. Only 11.7% achieved all three goals. In statin-treated patients, we found a statistically significant difference between patients with and without cardiovascular disease on the prevalence of patients reaching the target HDL-C (68.1 vs 35.4%; p=0.001). There were no differences in the prevalence of patients who achieved LDL-C and triglyceride goals.Discussion/conclusionThere is a suboptimal utilization of statins and a substantial percentage of diabetic patients that do not achieve the therapeutic goals. We emphasize the need for an effort to optimize the lipid profile of diabetics in order to contribute to reducing the prevalence of cardiovascular diseases in this population